Extractos alergénicos para inmunoterapia en Latinoamérica

Ricardo Cardona-Villa, Andres Sánchez-Caraballo, Désirée Larenas-Linnemann, Edgardo José Járes-Jais, Jorge Mario Sánchez-Caraballo

Resumen


La Sociedad Latinoamericana de Alergia, Asma e Inmunología (SLAAI), presenta un documento acerca del uso de la inmunoterapia en Latinoamérica, revisando los patrones de administración, indicaciones y contraindicaciones, efectos sobre la salud, eventos adversos e impacto socioeconómico. Esta revisión pretende ser un enfoque práctico de la información científica disponible en América Latina sobre la inmunoterapia y hacer un paralelo a lo observado en países de Europa y en Estados Unidos.


Palabras clave


Alergia; Alérgeno; Inmunoterapia; América Latina; Subcutáneo; Sublingual; Trópico.

Texto completo:

Pre-print

Referencias


Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https://doi.org/10.1136/bmj.d5928

Rincón C, Velarde T. Eficacia de la inmunoterapia para el tratamiento de la urticaria crónica (hiposensibilización rápida). Sanidad Militar Mexico. 2001;55(5):190-3. http://alturl.com/27yvz

Guimarães Junqueir de Queirós M, Oliveira Silva DA, Alves R, Fukuhara Chiba H, Soares de Amaral VB, de Almeida KC. Mite-specific immunotherapy using allergen and/or bacterial extracts in atopic patients in Brazil. J Investig Allergol Clin Immunol. 2008;18(2):84-92.

Queirós MG, Silva DA, Siman IL, Ynoue LH, Araújo NS, Pereira FL. Modulation of mucosal/systemic antibody response after sublingual immunotherapy in mite-allergic children. Pediatr Allergy Immunol. 2013;24(8):752-61http://alturl.com/r7sy9

Socci M, Slullitel P, Cortigiani L. Efficacy of Immnunotherapy with an Oral Bacterial Lysate and Vitamin C in the Primary Prevention of Acute Respiratory Tract Infections in Children. WAO Journal. 2012;5(Suppl 2):S69. http://alturl.com/ggbia http://onlinelibrary.wiley.com/doi/10.1111/pai.12163/abstract

Baena-Cagnani CE, Larenas Linnemann D, Gómez M, Díaz SG, Solé D, Borges MS. Allergy training and immunotherapy in Latin America: results of a regional overview. Ann Allergy Asthma Immunol. 2013;111(5):415-9.e1.http://rmedicina.ucsg.edu.ec/archivo/14.3/RM.14.3.01.pdf

Cardona R, Lopez E, Beltrán J, Sánchez J. Safety of immunotherapy in patients with rhinitis, asthma or atopic dermatitis using an ultra-rush buildup. A retrospective study. Allergol Immunopathol (Madr). 2014;42(2):90-5.

Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010;125(3):569-74, 74.e1-74.e7.

Santos N, Pereira AM, Silva R, Torres da Costa J, Plácido JL. Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010. Allergol Immunopathol (Madr). 2015;43(1):25-31.

Cardona R, Chinchilla C, Ramirez R, Olivares M, Calvo V, Maspero J. A study assessing the safety and efficacy of subcutaneous immunotherapy with a dust mite vaccine with the adjuvant l-tyrosine in a highly sensitized population in a Latin-American city. WAO Journal. 2014;7(Suppl 1):P22. https://link.springer.com/article/10.1186/1939-4551-7-S1-P22

Molina-Sáenz MM, Villa-Arango AM, Cardona-Villa R. Safety of subcutaneous immunotherapy with tyrosine-adsorbed house dust mite extracts in patients with allergic disease]. Rev Alerg Mex. 2017;64(1):52-65. http://alturl.com/7uht3

Castelblanco I, Gómez P, Cardona R. Determinación de la seguridad de la inmunoterapia subcutánea con extractos polimerizados de Dermatophagoides farinae, Dermatophagoides pteronyssinus y Blomia tropicalis administrada en pacientes con enfermedad alérgica. Medicina & Laboratorio. 2016;22(7):365-80.

Morales M, Fernández R, Morales M, Pérez M. Comportamiento del tratamiento con vacunas antialérgicas en pacientes alérgicos. Revista Archivo Médico de Camagüey. 2010;14(3):1-15.

Sosa Jiménez G, López García A, Galindo García JA, Paz Martínez D, Carrillo Tamez R, Papaqui Tapia S. Incidence of adverse reactions to immunotherapy in allergic patients at Puebla University Hospital. Rev Alerg Mex. 1998;45(6):147-9.http://scielo.sld.cu/pdf/amc/v14n3/amc030310.pdf

Rodríguez Santos O. Sublingual immunotherapy in allergic rhinitis and asthma in 2-5 year-old children sensitized to mites. Rev Alerg Mex. 2008;55(2):71-5.

Rodríguez O, Reyes-Almaguer MdC. Efficacy and safety of sublingual immunotherapy in children aged 6-24 months with rhinitis and bronchial asthma sensitized to house dust mites. VacciMonitor. 2015;24(2):86-92.

Rodríguez N, Ambriz M, Pizarro U. Reacciones sistémicas no fatales por inmunoterapia y pruebas cutáneas. Revista Alergia Mexico. 2002;49(3):69-73.

Rodríguez Pérez N, Ambriz Moreno MeJ. [Safety of immunotherapy and skin tests with allergens in children younger than five years]. Rev Alerg Mex. 2006;53(2):47-51.

Ávila Castañón L, Lerma-Ortiz L, Velázquez Armenta Y, del Rio Navarro BE, Sienra Monge JJ. [Adverse reactions to immunotherapy in pediatric patients]. Rev Alerg Mex. 2003;50(5):182-6.

González-Díaz SN, de la Rosa-López JH, Arias-Cruz A, Macías-Weinmann A, Herrera-Castro D, Rodríguez-Ortíz P. Related systemic reactions to allergen immunotherapy in Monterrey, Mexico. Rev Alerg Mex. 2011;58(2):79-86.

Rodríguez-Pérez, N., de Jesús Ambriz-Moreno, M., Canonica, G. W., & Penagos, M. (2008). Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy. Annals of Allergy, Asthma & Immunology, 101(3), 304-310.

Larenas Linnemann D, Rodríguez Pérez N, Becerril M. Adverse reactions to skin tests and immunotherapy in the practice of Mexican allergologists. Rev Alerg Mex. 2008;55(2):62-70.

Moncayo Coello CV, Rosas Vargas MA, del Rio Navarro BE, Lerma Ortiz L, Velázquez Armenta Y, Sienra Monge JJ. [Quality of life in children with allergic rhinitis before and after being treated with specific immunotherapy (cases and controls)]. Rev Alerg Mex. 2003;50(5):170-5.

Yepes-Núñez JJ, Gómez C, Espinoza Y, Cardona R. The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma. Biomedica. 2014;34(2):282-90.

Solari JE, Loo J, Felices A, Casas J. Immunotherapy for patients with persistent allergic rhinitis unsatisfied with free chronic pharmacotherapy. Allergol Immunopathol (Madr). 2006;34(3):102-6.

Rodríguez Santos O. [Sublingual immunotherapy with allergenic extract of Dermatophagoides pteronyssinus in asthmatic children]. Rev Alerg Mex. 2004;51(5):177-80.

Rodríguez Medina R, López Durán JL, Gasca Bauza MR, Cortéz González E, Zamora Limón E. [Effect of immunotherapy with allergens in asthmatic children with integral treatment]. Rev Alerg Mex. 2000;47(5):162-5.

Skrie V. Inmunoterapia con alergenos en niños menores de 5 años con asma bronquial. Doctoral Thesis, National University of Cordoba, Faculty of Medical Sciences. 2009.

Baptistella E, Maniglia S, Malucelli DA, Rispoli D, Pruner de Silva T, Tsuru FM. Allergen-specific immunotherapy in patients 55 years and older: results and review of literature. Int Arch Otorhinolaryngol. 2013;17(4):375-9.

Sánchez, J., Restrepo, M., Diez, S., & Cardona, R. (2012). Comparación del efecto clínico de la inmunoterapia en pacientes con asma alérgica según la edad y el patrón de sensibilización. Alerg Asma Inmunol Pediatr, 21(3), 77-85.

Barrera T. Efectos de la Inmunoterapia sobre la hiperreactividad bronquial de pacientes con rinitis alérgica. Doctoral Thesis, National University of Cordoba, Faculty of Medical Sciences. 2009.

Santos S, Chaves C, Lemos S, Pinheiro J. Alergia a veneno de himenópteros na criança. Scientia Medica (Porto Alegre) 2012;22(4):203-7.

Guzmán M MA, Salinas L J, Toche P P, Marinovic M MA, Gallardo O AM. [Immunotherapy against hymenoptera venom: report of ten patients]. Rev Med Chil. 2007;135(12):1566-71.

Sánchez Caraballo JM, Cardona Villa R. Clinical and immunological changes of immunotherapy in patients with atopic dermatitis: randomized controlled trial. ISRN Allergy. 2012;2012:183983.

Sánchez J, Cardona R. Effect of immunotherapy on basophil activation induced by allergens in patients with atopic dermatitis. Rev Alerg Mex. 2014;61(3):168-77.

López-Piedrahita E, Sánchez-Caraballo JM, Ramírez-Girado RH, Cardona-Villa R. Effectiveness of allergen immunotherapy in patients with vernal keratoconjuctivitis. Rev Alerg Mex. 2013;60(1):11-6.

Núñez JA, Cuesta U. Local conjunctival immunotherapy: the effect of dermatophagoides pteronyssinus local conjunctival immunotherapy on conjunctival provocation test in patients with allergic conjunctivitis. Allergol Immunopathol (Madr). 2000;28(6):301-6.

Medeiros M, Lyra A, Santos H, Mendes C, Almeida K, Silva D. Eficácia clínica da imunoterapia nasal comparada com imunoterapia sublingual em pacientes com rinite alérgica. Rev bras alerg imunopatol. 2009;32(1):13-7.

Zavadniak A, Rosário-Filho N, Arruda K, Morato F, Solé D, Aun W. Verificação da potência de extratos alergênicos comerciais de Dermatophagoides pteronyssinus para imunoterapia. Rev bras alerg imunopatol. 2004;27(2):46-54.

Rosas Alvarado A, López López JR. Basis to modify the immunotherapy regimen at the Allergy Service, General Hospital of Mexico. Rev Alerg Mex. 2010;57(4):107-11.

Siman IL, de Aquino LM, Ynoue LH, Miranda JS, Pajuaba AC, Cunha-Júnior JP. Allergen-specific IgG antibodies purified from mite-allergic patients sera block the IgE recognition of Dermatophagoides pteronyssinus antigens: an in vitro study. Clin Dev Immunol. 2013;2013:657424.

Velázquez BL, Segura DL, Barbosa DE, Vázquez MI, Tapia JG, Altamirano SC. Determination of interleukins and IgG4 in patients with allergic rhinitis with and without immunotherapy. Rev Alerg Mex. 2004;51(4):139-44.

Yang C, Arruda K, Santos R, Barbosa R, Chapman D, Castro K. Cross-reactivity between dust mite and shrimp: what is the effect of immunotherapy? JACI. 2009;125(2):AB35. DOI: http://dx.doi.org/10.1016/j.jaci.2009.12.168

Castro R, Souza K, Yang A, Morato F, Galvão C, Mari A. New manioc allergens and successful oral immunotherapy in a Brazilian allergic patient. WAO Journal. 2015;8:A181.

Mouchián D, Albónico J, Potenza M, Bignone M, Rodríguez S, Irañeta S. Utilidad de los péptidos 33 y 38 de Lolium perenne en la inmunoterapia de la rinitis polínica. Revista de la Asociación Médica Argentina. 2014;127(1):8-19.

Fonseca DM, Wowk PF, Paula MO, Gembre AF, Baruffi MD, Fermino ML. Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy. Allergy. 2015;70(3):275-84.

Escobar A, Aguirre A, Guzmán MA, González R, Catalán D, Acuña-Castillo C. Tolerogenic dendritic cells derived from donors with natural rubber latex allergy modulate allergen-specific T-cell responses and IgE production. PLoS One. 2014;9(1):e85930.

Smaldini PL, Orsini Delgado ML, Fossati CA, Docena GH. Orally-Induced Intestinal CD4+ CD25+ FoxP3+ Treg Controlled Undesired Responses towards Oral Antigens and Effectively Dampened Food Allergic Reactions. PLoS One. 2015;10(10):e0141116.

Sato MN, Carvalho AF, Silva AO, MacIel M, Fusaro AE, Duarte AJ. Low dose of orally administered antigen down-regulates the T helper type 2-response in a murine model of dust mite hypersensitivity. Immunology. 1999;98(3):338-44.

Ruiz FJ, Jiménez A, Cocoletzi J, Durán E. Compliance with and abandonment of immunotherapy. Rev Alerg Mex. 1997;44(2):42-4.

Sánchez J. Adherence to allergen immunotherapy improves when patients choose the route of administration: Subcutaneous or sublingual. Allergol Immunopathol (Madr). 2015;43(5):436-41.

Gallardo Martínez G, Arias Cruz A, González Díaz SN, Galindo Rodríguez G. Costs due to asthma medical care in a group of children from northeastern Mexico. Rev Alerg Mex. 2007;54(3):82-5.

Sánchez J, Sánchez A, Cardona R. Economic consequences in real life of allergen immunotherapy in asthma, rhinitis and dermatitis. Rev Alerg Mex. 2016;63(4):323-33.

Sanchez J, Diez S, Cardona R. Sensibilización a aeroalergenos en pacientes alérgicos de Medellín, Colombia Revista Alergia México. 2012;59(3):139-47.

Forno E, Gogna M, Cepeda A, Yañez A, Solé D, Cooper .Asthma in Latin America. Thorax. 2015;70(9):898-905.




DOI: http://dx.doi.org/10.29262/ram.v0i0.287

Enlaces refback

  • No hay ningún enlace refback.


Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.